Evidence map›Paper›PMID 29422087›Full record

ArticleParasites & vectors2018

Integrated vector control of Aedes aegypti mosquitoes around target houses.

Roberto Barrera, Manuel Amador, Jorge Munoz, Veronica Acevedo

Abstract read
In one paragraph

Article in Parasites & vectors, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Field evaluation of the efficacy of ovillanta ovitrap towardsParasite epidemiology and control · 2026
    Article
  5. Strategies for controllingCaribbean journal of science · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Oviposition Preferences of Aedes aegypti in Msambweni, Kwale County, Kenya.Journal of the American Mosquito Control Association · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Improving the Safety and Acceptability of Autocidal Gravid Ovitraps (AGO Traps).Journal of the American Mosquito Control Association · 2021
    Article
  18. Article
  19. Globe-TrottingVector borne and zoonotic diseases (Larchmont, N.Y.) · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Roberto BarreraEntomology and Ecology Activity, Dengue Branch, Centers for Disease Control and Prevention, 1324 Calle Canada, San Juan, 00920, Puerto Rico. amz9@cdc.gov.
Manuel AmadorEntomology and Ecology Activity, Dengue Branch, Centers for Disease Control and Prevention, 1324 Calle Canada, San Juan, 00920, Puerto Rico.
Jorge MunozMolecular Diagnostic Laboratory, Dengue Branch, Centers for Disease Control and Prevention, 1324 Calle Canada, San Juan, 00920, Puerto Rico.
Veronica AcevedoEntomology and Ecology Activity, Dengue Branch, Centers for Disease Control and Prevention, 1324 Calle Canada, San Juan, 00920, Puerto Rico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe developing fetuses of pregnant women are at high risk of developing serious birth defects following Zika virus infections. We applied an Integrated Vector Control (IVC) approach using source reduction, larviciding, and mass trapping with non-insecticidal sticky traps to protect targeted houses by reducing the density of female Aedes aegypti mosquitoes.

methodsWe tested the hypothesis that Ae. aegypti density could be reduced to below three female mosquitoes/trap/week around a target house in the center of a circular area with a 150 m radius using IVC. Two non-adjacent areas within the same neighbourhood were selected and randomly designated as the treatment or control areas. Sentinel Autocidal Gravid Ovitraps (SAGO traps) were placed in each study area and were sampled weekly from May to November, during the 2016 Zika epidemic in Puerto Rico. The experimental design was longitudinal with pre-and post-IVC treatment observations between treatment and control areas, and a partial cross-over design, where IVC was applied to the original control area after 2 months to determine if Ae. aegypti density converged to levels observed in the treatment area. Pools of female Ae. aegypti mosquitoes were analyzed by RT-PCR to detect Zika, dengue and chikungunya virus RNA.

resultsOverall, pre-treatment mosquito densities in the inner (0-50 m; 15.6 mosquitoes/trap/week), intermediate (50-100 m; 18.1) and outer rings (100-150 m; 15.6) were reduced after treatment to 2.8, 4.1, and 4.3 in the inner, middle, and outer rings, respectively. Density at the target house in the treatment area changed from 27.7 mosquitoes/trap/week before IVC to 2.1 after IVC (92.4% reduction), whereas after treating the original control area (cross-over) density changed from 22.4 to 3.5 (84.3% reduction). Vector reductions were sustained in both areas after IVC. Zika virus was detected in Ae. aegypti, but the low incidence of the virus precluded assessing the impact of IVC on Zika transmission during the study.

conclusionsApplying IVC to circular areas that were surrounded by untreated areas significantly decreased the number of mosquitoes around target houses located in the center. Gravid Ae. aegypti females in the center of the 150 m areas fell below threshold levels that possibly protect against novel invading arboviruses, such as chikungunya and Zika.

Indexed as

AedesAnimalsChikungunya virusCross-Over StudiesDengue VirusFamily CharacteristicsFemaleHumansLongitudinal StudiesMosquito ControlMosquito VectorsPopulation DensityPuerto RicoReverse Transcriptase Polymerase Chain ReactionRNA, ViralZika VirusRNA, ViralAedes aegyptiAGO trapsMosquitoesVector controlZika

Identifiers

PMID29422087
PMCPMC5804079

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.